Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Drug Discovery & Development
Targeting oxMIF To Develop Novel Biotherapeutics
An interview with Michael Thiele, Chief Scientific Officer, OncoOne Research & Development GmbH.
Immunotherapy (Non-Oncology)
Exploring the Role of IFNa in Autoimmunity & Infection
On-Demand Webinar featuring Dr Darragh Duffy, LabEx Coordinator at Institut Pasteur
Drug Discovery & Development
Novel TNF Superfamily Antagonists for Cancer & Autoimmunity
An interview with Russell LaMontagne, Co-Founder and Chief Executive Officer, Boston Immune Technologies and Therapeutics
Drug Discovery & Development
Antibody Discovery by Single B Cell Screening on Beacon®
On-Demand Webinar featuring Dr Amy Sheng, Technical Account Manager at Sino Biological
3D Cell Culture
In Conversation With...Stefan Przyborski, Professor, Durham University
In this video Q&A we discuss Stefan's recent work with bioengineered human tissues and the challenges to adopting 3D cell culture technologies in research.
Drug Discovery & Development
Experts Discuss Developing Oncolytic Virus Immunotherapy
Our November Immuno-Oncology Discussion Group brought together experts in the field of oncolytic virus development to discuss engineering and translational strategies of the field
Drug Discovery & Development
What are the Key Challenges in Developing Bispecific Antibodies for Cancer Immunotherapy?
Are there too many opportunities in antibody-based immunotherapy? How do you choose your targets? How do you know when to kill a project?
Manufacturing & Bioprocessing
Q &A with Shilpi Rajoria
An interview Shilpi Rajoria, Director QC Analytical Testing at Bristol Myers Squibb.
3D Cell Culture
Advanced and Predictive 3D Cell Culture Models
Elodie Vandenhaute, Project Director at HCS Pharma, leads a discussion group on utilising multi-cell type models to understand diseases, cells, and therapeutic mechanisms.
Manufacturing & Bioprocessing
Accelerating Upstream Process Development with Direct CQA and Media Analysis Feedback
Upstream Bioprocess Development.
Biomarkers & Precision Medicine
Enabling Ultrasensitive Protein Quantification with the Quanterix Homebrew Kit
Unique Homebrew Kits give researchers the flexibility to develop custom Simoa assays.
Cell Line Development
Experience the Next Generation in Clonality
Explore the future of single cell seeding.